|12.96||+0.2000||+1.57%||Vol 95.22K||1Y Perf -8.86%|
|Jun 24th, 2022 16:00 DELAYED|
|- -||- -%|
|Target Price||22.33||Analyst Rating||Strong Buy 1.00|
|Potential %||72.30||Finscreener Ranking||— -|
|Insiders Trans % 3/6/12 mo.||-/-/-||Value Ranking||+ 36.27|
|Insiders Value % 3/6/12 mo.||-/-/-||Growth Ranking||★+ 40.68|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-/-||Income Ranking||— -|
|Price Range Ratio 52W %||44.21||Earnings Rating||—|
|Market Cap||594.46M||Earnings Date||12th May 2022|
Today's Price Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||-0.11|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||127.13K|
|Avg. Monthly Volume||88.30K|
|Avg. Quarterly Volume||77.86K|
Bioceres Crop Solutions Corp. (AMEX: BIOX) stock closed at 12.96 per share at the end of the most recent trading day (a 1.57% change compared to the prior day closing price) with a volume of 95.22K shares and market capitalization of 594.46M. Is a component of indices and it is traded on AMEX exchange. The company belongs in the Agriculture industry, Basic Materials sector and employs 447 people. Bioceres Crop Solutions Corp. CEO is Federico Trucco.
The one-year performance of Bioceres Crop Solutions Corp. stock is -8.86%, while year-to-date (YTD) performance is -8.35%. BIOX stock has a five-year performance of %. Its 52-week range is between 10.21 and 16.43, which gives BIOX stock a 52-week price range ratio of 44.21%
Bioceres Crop Solutions Corp. currently has a PE ratio of -320.60, a price-to-book (PB) ratio of 6.31, a price-to-sale (PS) ratio of 1.81, a price to cashflow ratio of 53.90, a PEG ratio of 2.32, a ROA of -0.36%, a ROC of 2.83% and a ROE of -2.08%. The company’s profit margin is 0.65%, its EBITDA margin is 14.40%, and its revenue ttm is $307.95 Million , which makes it $6.71 revenue per share.
Of the last four earnings reports from Bioceres Crop Solutions Corp., there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.11 for the next earnings report. Bioceres Crop Solutions Corp.’s next earnings report date is -.
The consensus rating of Wall Street analysts for Bioceres Crop Solutions Corp. is Strong Buy (1), with a target price of $22.33, which is +72.30% compared to the current price. The earnings rating for Bioceres Crop Solutions Corp. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Bioceres Crop Solutions Corp. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Bioceres Crop Solutions Corp. has a Sell technical analysis rating based on Technical Indicators (ADX : 23.61, ATR14 : 0.75, CCI20 : -63.43, Chaikin Money Flow : 0.03, MACD : -0.34, Money Flow Index : 44.75, ROC : -13.89, RSI : 45.04, STOCH (14,3) : 31.62, STOCH RSI : 1.00, UO : 55.79, Williams %R : -68.38), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Bioceres Crop Solutions Corp. in the last 12-months were:
Thu, 12 May 2022 21:05 GMT Analysts Are Bullish on These Materials Stocks: Bioceres Crop Solutions (BIOX), Trulieve Cannabis (TCNNF)- TipRanks. All rights reserved.
Fri, 18 Mar 2022 12:45 GMT Bioceres Crop Solutions (BIOX) Gets a Buy Rating from Lake Street- TipRanks. All rights reserved.
Thu, 17 Mar 2022 10:13 GMT Bioceres Agrees to Merge with Marrone- TipRanks. All rights reserved.
Fri, 11 Feb 2022 13:35 GMT Bioceres Crop Solutions (BIOX) Receives a Buy from Lake Street- TipRanks. All rights reserved.
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
eToro USA LLC does not offer CFDs and makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication, which has been prepared by our partner utilizing publicly available non-entity specific information about eToro. Your capital is at risk.
This could take some time, please wait.